Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4
Chong Bao, Jing Zhang, Shu‐Yue Xian, et al.
Free Radical Research (2021) Vol. 55, Iss. 7, pp. 743-754
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
Kaiyue Ding, Chongbin Liu, Li Li, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 74
Ferroptosis and Its Potential Role in the Nervous System Diseases
Yiyang Zhou, Wei Lin, T. Rajeswara Rao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1555-1574
Open Access | Times Cited: 51
The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases
Molin Yang, Hanshen Luo, Xin Yi, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 36
Emerging role of miRNAs in the regulation of ferroptosis
Reza Mahmoudi-Lamouki, Sepideh Kadkhoda, Bashdar Mahmud Hussen, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 23
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
Xiaojie Zhang, Bufu Tang, Jinhua Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Ferroptosis: mechanisms and therapeutic targets
Qian Zhou, Yu Meng, Jiayuan Le, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 9
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy
Mobarakeh Ajam-Hosseini, Sadegh Babashah
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1
Relationship between miRNA and ferroptosis in tumors
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma
Peng Xu, Feihang Ge, Wenxin Li, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 33
Ferroptosis Involvement in Glioblastoma Treatment
Andrei-Otto Mitre, Ioan Alexandru Florian, Andrei Buruiană, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 319-319
Open Access | Times Cited: 30
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs
Qi Zhang, Xinfeng Fan, Xinyu Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
Izadora de Souza, Maria Carolina Clares Ramalho, Camila Banca Guedes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6879-6879
Open Access | Times Cited: 26
Ferroptosis Inhibitors as Potential New Therapeutic Targets for Cardiovascular Disease
Soghra Farzipour, Zahra Shaghaghi, Shokouh Motieian, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 2271-2286
Closed Access | Times Cited: 25
Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters
Mehdi Rabiee Valashedi, Chia Bamshad, Nima Najafi-Ghalehlou, et al.
Human Cell (2022) Vol. 35, Iss. 4, pp. 972-994
Closed Access | Times Cited: 24
The Regulation of Ferroptosis by Noncoding RNAs
Xiangnan Zheng, Cen Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13336-13336
Open Access | Times Cited: 15
The interplay of miRNAs and ferroptosis in diseases related to iron overload
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Modulation of Ferroptosis by microRNAs in Human Cancer
Irena Velkova, Martina Pasino, Zumama Khalid, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 719-719
Open Access | Times Cited: 13
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
Shenghua Zhuo, Guiying He, Taixue Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20
Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Ching‐Yu Yen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3688-3688
Open Access | Times Cited: 12
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
Emerging roles of ferroptosis-related miRNAs in tumor metastasis
Zhongyi Jiang, Jing Zhou, Junqi Deng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
The Role of Ferroptosis in Atrial Fibrillation: A Promising Future
Jiabin Zhou, Ling‐Ling Qian, Dan Wu, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 4, pp. 127-127
Open Access | Times Cited: 4
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
Page 1 - Next Page

Scroll to top